Clinical outcomes of CyberKnife stereotactic radiotherapy for localized prostate cancer: comparison of 35 Gy in 5 fractions and 36 Gy in 4 fractions
Journal of Radiation Research · 26.05.2026 · 67 (3) · 402-411
DOI: 10.1093/jrr/rrag017 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Radiation Research, online erschienen am 14.04.2026. Verfasst von Jiyoon Lim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, South K…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Radiosurgery, Dose Fractionation, Radiation. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National IT Industry Promotion Agency and the Gangwon Information & Culture Industry Promotion Agency, Ministry of Science and ICT, Data-based Magnetic Modulated Radiation Therapy: Commercialization and Validation.
Abstract (Originalsprache)
This retrospective study evaluated the clinical outcomes of two CyberKnife (CK) stereotactic body radiation therapy (SBRT) regimens in patients with localized prostate cancer (LPC). A total of 249 patients were treated, with 123 receiving 35 Gy in 5 fractions and 126 receiving 36 Gy in 4 fractions, with a median follow-up of 50 months. The primary endpoint was the incidence of grade ≥2 genitourinary (GU) and gastrointestinal (GI) toxicities, assessed using CTCAE Version 5.0. Secondary endpoints included 3-year biochemical recurrence-free survival (BCRFS), locoregional recurrence-free survival (LRRFS) and distant metastasis-free survival (DMFS). To address baseline imbalances between groups, inverse probability of treatment weighting (IPTW) was applied. Acute grade 2 GU toxicities occurred in 19 patients (7.6%) and chronic grade 2 in 15 patients (6.0%). Acute and chronic grade 2 GI toxicities were rare, occurring in 3 (1.2%) and 2 (0.8%) patients, respectively. There were no significant differences in cumulative GU or GI toxicity rates between fractionation regimens either before or after IPTW adjustment. After IPTW, the 3-year BCRFS was 96.5% in the 5-fraction group and 96.8% in the 4-fraction groups (P = 0.571). The 3-year LRRFS rates were similarly favorable (99.2% vs. 100%). The 3-year DMFS was 100% in the 5-fraction group and 97.5% in the 4-fraction group (P = 0.058). Overall, CK-SBRT using 36 Gy in 4 fractions was well tolerated, with low rates of treatment-related toxicity and no statistically significant differences in oncologic outcomes between regimens. Longer follow-up is required to determine the long-term efficacy of this dose-escalation strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, South Korea.
- Department of Radiation Oncology, Yeungnam University Medical Center, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, South Korea.
- Department of Radiation Oncology, Kangwon National University Hospital, 156 Baengnyeong-ro, Chuncheon-si, Gangwon-do 24289, South Korea.
ORCID-Profile: Jiyoon Lim, Sumin Lee, Yeon J Kim
Förderung
- National IT Industry Promotion Agency and the Gangwon Information & Culture Industry Promotion Agency
- Ministry of Science and ICT
- Data-based Magnetic Modulated Radiation Therapy: Commercialization and Validation
Zitieren
APA
Lim, J., Jo, Y. Y., Lee, S., & Kim, Y. J. (2026). Clinical outcomes of CyberKnife stereotactic radiotherapy for localized prostate cancer: comparison of 35 Gy in 5 fractions and 36 Gy in 4 fractions. Journal of Radiation Research, 67(3), 402-411. https://doi.org/10.1093/jrr/rrag017
Vancouver
Lim J, Jo YY, Lee S, Kim YJ. Clinical outcomes of CyberKnife stereotactic radiotherapy for localized prostate cancer: comparison of 35 Gy in 5 fractions and 36 Gy in 4 fractions. Journal of Radiation Research. 2026;67(3):402-411. doi:10.1093/jrr/rrag017
BibTeX
@article{Lim2026,
author = {Lim, Jiyoon and Jo, Yoon Y and Lee, Sumin and Kim, Yeon J},
title = {Clinical outcomes of CyberKnife stereotactic radiotherapy for localized prostate cancer: comparison of 35 Gy in 5 fractions and 36 Gy in 4 fractions},
journal = {Journal of Radiation Research},
year = {2026},
volume = {67},
number = {3},
pages = {402--411},
doi = {10.1093/jrr/rrag017}
}
EUVIMED